SGMO Retrace

Sangamo Therapeutics, Inc.NASDAQ

الوصف

⋅ ٢ تموز يوليو ٢٠١٩ ٠٢:١٩

SGMO will retrace slightly before its FDA approval, still trading above 100 EMA, MFI/RSI cooling off.